What are the recommended surveillance guidelines for a 77‑year‑old nonsmoker with incidentally discovered solid pulmonary nodules in the left lower lobe—a 6‑mm subpleural nodule and a 5‑mm pleural‑based nodule?

Surveillance Guidelines for 6 mm and 5 mm Solid Subpleural Nodules in a 77-Year-Old Nonsmoker

Direct Recommendation

For this 77-year-old nonsmoker with a 6 mm and 5 mm solid subpleural nodules, I recommend a single follow-up low-dose CT at 12 months, and if stable, no further surveillance is needed. 1

---

Risk Stratification

The malignancy risk for these nodules is extremely low:

• Nodules <6 mm have <1% malignancy risk even in high-risk patients 1, 2
• The 6 mm nodule carries approximately 0.5-2% malignancy risk 1, 2
• Nonsmoker status dramatically reduces risk (relative risk only 0.15 compared to heavy smokers) 3
• Age 77 is relevant but far less concerning without smoking history 4

---

Specific Surveillance Protocol

Initial Follow-Up Timing

• Perform low-dose CT at 12 months for the 6 mm nodule 1, 4
• The 5 mm nodule requires no routine follow-up in a low-risk patient 1
• If both nodules are unchanged at 12 months, surveillance can stop 4, 5

Technical Imaging Requirements

• Use thin-section CT (≤1.5 mm slices, ideally 1.0 mm) with multiplanar reconstructions 1, 3
• Low-dose, non-contrast technique to minimize radiation exposure 1, 4, 3
• No IV contrast is required for nodule surveillance 1, 3

---

Critical Nodule Features to Assess on Follow-Up

Before finalizing this recommendation, the radiologist must evaluate these morphologic features on thin-section CT:

Features Suggesting Benignity (No Follow-Up Needed)

• Triangular or lentiform shape with smooth margins typical of intrapulmonary lymph nodes 1, 6
• Linear extension to pleural surface characteristic of benign pleural-attached nodules 1, 6
• Perifissural location with oval/triangular morphology 5, 7, 6
• Any benign calcification pattern (diffuse, central, laminated, or popcorn) 1, 5

Features Warranting Closer Surveillance

• Spiculated or irregular margins 1, 4, 7
• Upper lobe location (your nodules are lower lobe, which is reassuring) 1, 4
• Part-solid or ground-glass components (requires different algorithm) 1, 4, 5
• Lobulation, pleural indentation, or vascular convergence 7

---

Important Caveats and Pitfalls

What NOT to Do

• Do not order PET/CT for nodules <8 mm due to limited spatial resolution 1, 4, 3
• Do not perform biopsy at this stage given extremely low pretest probability 4, 2
• Do not use chest radiography for follow-up (sensitivity too poor for nodules <1 cm) 1, 5
• Do not order contrast-enhanced CT as it adds no value for nodule surveillance 1, 3

Common Errors to Avoid

• Failure to obtain thin-section CT leads to inaccurate characterization and measurement 4, 5
• Assuming all pleural-based nodules are suspicious when many represent benign intrapulmonary lymph nodes 1, 6
• Ordering follow-up at 3-6 months is too aggressive for this low-risk scenario 1
• Continuing surveillance beyond 2 years if nodules remain stable is unnecessary 5, 8

---

When to Escalate Management

Proceed to PET/CT, biopsy, or surgical consultation if: 4, 5

• Any growth detected on 12-month follow-up 4, 5
• New concerning morphologic features appear (spiculation, irregular margins) 4, 7
• Development of solid component in a previously ground-glass nodule 4

---

Special Considerations for This Patient

Age and Life Expectancy

• At age 77, consider life-limiting comorbidities when deciding whether surveillance benefit outweighs risk 5
• Shared decision-making is appropriate if significant comorbidities exist 5

Multiple Nodules

• Manage based on the dominant (most suspicious) nodule, which is the 6 mm lesion 1
• Monitor both nodules on follow-up imaging even though the 5 mm nodule doesn't drive the surveillance schedule 1

Patient Anxiety

• If patient is highly anxious, consider earlier follow-up at 6 months rather than 12 months 4, 3
• Explain the <1-2% malignancy risk to provide reassurance 3, 2